Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speaker and Moderator Disclosures

Ziad Awad - Nothing to disclose
Brian Davis - Nothing to disclose
Juliana Henrique - Nothing to disclose
Kevin Jacob  - Nothing to disclose
Amy Li  - Nothing to disclose
Luca Morelli - Nothing to disclose
Mayank Roy - Nothing to disclose
Yoshihiro Sakamoto - Nothing to disclose
Whiyie Sang - Nothing to disclosese
Sergio Silveira - Nothing to disclose
Iswanto Sucandy  - Nothing to disclose
Rodrigo Surjan - Nothing to disclose
Brendan Visser - Nothing to disclose

Video-based Education Committee Disclosures

Adam J. Doyle, MD, FACS  -  Nothing to disclose
Angela Kokkosis, MD, FACS -  Nothing to disclose
Ankit D. Patel, MD, FACS -  Nothing to disclose
Barbara A. Gaines, MD, FACS  -  Nothing to disclose
Barnard J. Palmer, MD, FACS -  Nothing to disclose
Benjamin Poulose, MD, MPH, FACS  - ACHQC: Salary Support: Director of Quality and Outcomes, BD Interventional: Research Support: Co-PI, Advanced Medical Solutions: Research Support: Co-PI
Brian P. Jacob, MD, FACS - International Hernia Collaboration: Equity: Founder, Medtronic: Honorarium/Grant for Meeting: Education
Brian R. Davis, MD, FACS - Nothing to disclose
Ceana H. Nezhat, MD, FACS - Plasma Surgical: Honorarium: Medical Advisor, Karl Storz Endoscopy: Honorarium: Medical Advisor, Lumenis: Honorarium: Medical Advisor, Novuson Surgical: Honorarium: Medical Advisor, Baxter: Honorarium: Medical Advisor, Aesculap: Honorarium: Medical Advisor, Predictive Laboratories: N/A: Medical Advisor
Christopher Kalmar, MD -   Nothing to disclose
Dana A. Telem, MD, MPH, FACS - Medtronic: Research Funding: Study PI
Daniel M. Herron, MD, FACS, FASMBS -  Lexington Medical: Equity Options: Consultant
David J. Rowe, MD, FACS - Nothing to disclose
Don J. Selzer, MD, FACS - Cook Biotech, Inc.: Consultant Fees: Medical Advisor, Becton Dickinson, Inc.: Consultant Fees: Medical Advisor
Eren Berber, MD, FACS - Ethicon: Honoraria for Consulting: Consulting, Medtronic: Honoraria for Consulting: Consulting, Aesculap: Honoraria for Consulting: Consulting, Integra: Honoraria for Consulting: Consulting
Flavio G. Rocha, MD, FACS - Nothing to disclose
Giovanni Dapri, MD, PhD, FACS -  Nothing to disclose
Gustavo G. Fernandez-Ranvier, MD, PhD, FACS -  Nothing to disclose
Imran Hassan, MBBS, FACS - Nothing to disclose
J. Scott Roth, MD, FACS - Becton Dickinson/CR Bard: Honoraria, Grant: Consultant, Investigator, Miromatrix: Stock Options: Consultant, Johnson & Johnson: Honoraria: Consultant
Jacob Moalem, MD, FACS -  Nothing to disclose
Joseph Scharpf, MD, FACS - Nothing to disclose
Krystal L. Tomei, MD, FACS - Nothing to disclose
Lee M. Morris, MD, FACS - Boston Scientific: Monetary Compensation: Consultant
Leena Khaitan, MD, FACS - Ethicon: Honoraria: Teaching/Research, Gore: Honorarium: Teaching
Leslie A. Deane, MBBS, FRCSC, FACS -  Nothing to disclose
Lindsay Tse, DO -  Nothing to disclose
Manu S. Sancheti, MD, FACS -  Intuitive: Honorarium: Speaker, Surgeon Educator, Mentor
Mark E. Zafereo, MD, FACS - Eli Lilly: Research Grant Funding: PI of Clinical Trial, Merck: Research Grant Funding: PI of Clinical Trial, Eli Lilly: Cash Stipend, Medical Advisory Board
Nader M. Hebela, MD, FACS -Nothing to disclose
Patricia Sylla, MD, FACS -   Ethicon: Consulting Fee: Consulting, Medtronic: Consulting Fee: Consulting, Olympus: Consulting Fee: Consulting, Karl Storz: Consulting Fee: Consulting, Safeheal: Consulting Fee: Consulting, ColubrisMX: Consulting Fee: Consulting, GI Windows: Consulting Fee: Consulting
Patrick B. Garvey, MD, FACS -  Nothing to disclose
Patrick R. Reardon, MD, FACS -  Johnson & Johnson: Honorarium: Advisory Board
Paul F. Rider, MD, FACS -  Nothing to disclose
Radu Apostol, DO, FACS -  Nothing to disclose
Rami Lutfi, MD, FACS - Nothing to disclose
Ramyar Gilani, MD, FACS - Nothing to disclose
Rockson C. Liu, MD, FACS - Intuitive Surgical: Honorarium: Consultant, BARD: Honorarium: Advisory Board, Medtronic: Honorarium: Speaking Engagement
Roman V. Petrov, MD, FACS - Nothing to disclose
Sean J. Langenfeld, MD, FACS -   Nothing to disclose
Sharon L. Stein, MD, FACS - Merck: Honorarium Research Funding: Speaking, Research, Smith: Honorarium: Consulting
Sharona B. Ross, MD, FACS - Intuitive Surgical: Honorarium: Consultant and Proctor
Shawn D. St. Peter, MD, FACS -  Nothing to disclose
Soham Roy, MD, FACS -  Nothing to disclose
Steven D. Schwaitzberg, MD, FACS - Human Extensions: Stock: Medical Advisor, Acuity Bio: Options: Medical Advisor, Activ Surgical: Options: Medical Advisor, Arch Therapeutics: Options: Medical Advisor, Levitra Magnetics: Options: Medical Advisor, Nu View Surgical: Options: Medical Advisor
Thomas J. Scharschmidt, MD, FACS -   Nothing to disclose
Toomas Anton, MD, FACS -  Nothing to disclose
Viraj Master, MD, FACS - Nothing to disclose
William B. Inabnet III, MD, FACS -   Nothing to disclose
William O. Richards, MD, FACS - Nothing to disclose
Ziad T. Awad, MD, FACS -  Nothing to disclose